INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2012

Evidence remains insufficient to confirm dietary interventions or PUFAs benefit multiple sclerosis.

Six randomized trials evaluated polyunsaturated fatty acids across 794 participants. Supplementation showed no meaningful impact on worsening disability after two years. Linoleic acid intake between 11 and 23 g/day conferred no benefit in 144 patients (RR 1.04, 95% CI 0.66 to 1.63), nor did 2.9 to 3.4 g/day in 65 progressive cases (RR 0.78, 95% CI 0.43 to 1.42). Omega-3 oils also showed no clear benefit in 292 relapsing-remitting participants (RR 0.82, 95% CI 0.65 to 1.03).

Study type
Systematic review and meta-analysis of randomized controlled trials
Who was studied
794 participants across 6 randomized controlled trials
What was measured
multiple sclerosis disease progression and relapse frequency

THE PAPER

Dietary interventions for multiple sclerosis.

Farinotti M, Vacchi L, Simi S, Di Pietrantonj C, Brait L, Filippini G. Cochrane Database Syst Rev, 2012.

PubMed 23235605 ↗DOI 10.1002/14651858.CD004192.pub3 ↗

Nutrients & adequacyBrain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.